BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38616622)

  • 1. Clinical validation of grass pollen exposure chamber in patients with allergic rhinitis triggered by timothy grass.
    Kosowska A; Zemelka-Wiącek M; Smolińska S; Wyrodek E; Adamczak B; Jutel M
    Clin Exp Allergy; 2024 Apr; ():. PubMed ID: 38616622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validated allergen exposure chamber is plausible tool for the assessment of house dust mite-triggered allergic rhinitis.
    Zemelka-Wiacek M; Kosowska A; Winiarska E; Sobanska E; Jutel M
    Allergy; 2023 Jan; 78(1):168-177. PubMed ID: 35980665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical and clinical validation of the Allergen BioCube
    Angjeli E; Gomes P; Lane KJ; Stein L; Abelson MB
    Immun Inflamm Dis; 2017 Mar; 5(1):78-84. PubMed ID: 28250927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber.
    Zemelka-Wiacek M; Kosowska A; Jutel M
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA
    Boelke G; Berger U; Bergmann KC; Bindslev-Jensen C; Bousquet J; Gildemeister J; Jutel M; Pfaar O; Sehlinger T; Zuberbier T
    Clin Transl Allergy; 2017; 7():33. PubMed ID: 28932387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid.
    Pfaar O; Hohlfeld JM; Al-Kadah B; Hauswald B; Homey B; Hunzelmann N; Schliemann S; Velling P; Worm M; Klimek L
    Clin Exp Allergy; 2017 Nov; 47(11):1445-1455. PubMed ID: 28696503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
    Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
    Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.
    Scadding GW; Calderon MA; Bellido V; Koed GK; Nielsen NC; Lund K; Togias A; Phippard D; Turka LA; Hansel TT; Durham SR; Wurtzen PA
    J Immunol Methods; 2012 Oct; 384(1-2):25-32. PubMed ID: 22759401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy?
    Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J
    Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyvalent Mechanical Bacterial Lysate Administration Improves the Clinical Course of Grass Pollen-Induced Allergic Rhinitis in Children: A Randomized Controlled Trial.
    Janeczek K; Emeryk A; Rachel M; Duma D; Zimmer Ł; Poleszak E
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):453-462. PubMed ID: 32858239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.
    Scadding GW; Eifan AO; Lao-Araya M; Penagos M; Poon SY; Steveling E; Yan R; Switzer A; Phippard D; Togias A; Shamji MH; Durham SR
    Allergy; 2015 Jun; 70(6):689-96. PubMed ID: 25773990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU).
    Ellis AK; Soliman M; Steacy LM; Adams DE; Hobsbawn B; Walker TJ
    Allergy Asthma Clin Immunol; 2016; 12():53. PubMed ID: 27777594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method for a homogeneous distribution of pollens in an environmental exposure chamber.
    Kenney P; Bønløkke J; Hilberg O; Ravn P; Schlünssen V; Sigsgaard T
    Clin Exp Allergy; 2016 Sep; 46(9):1176-84. PubMed ID: 27144495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients.
    Bergmann KC; Krause L; Hiller J; Becker S; Kugler S; Tapparo M; Pfaar O; Zuberbier T; Kramer MF; Guethoff S; Graessel A
    World Allergy Organ J; 2021 Jan; 14(1):100494. PubMed ID: 33376575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis.
    Krug N; Hohlfeld JM; Larbig M; Buckendahl A; Badorrek P; Geldmacher H; Behnke W; Dunkhorst W; Windt H; Loedding B; Luettig B; Koch W
    Clin Exp Allergy; 2003 Dec; 33(12):1667-74. PubMed ID: 14656353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.
    Zieglmayer P; Focke-Tejkl M; Schmutz R; Lemell P; Zieglmayer R; Weber M; Kiss R; Blatt K; Valent P; Stolz F; Huber H; Neubauer A; Knoll A; Horak F; Henning R; Valenta R
    EBioMedicine; 2016 Sep; 11():43-57. PubMed ID: 27650868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
    Scadding GW; Calderon MA; Shamji MH; Eifan AO; Penagos M; Dumitru F; Sever ML; Bahnson HT; Lawson K; Harris KM; Plough AG; Panza JL; Qin T; Lim N; Tchao NK; Togias A; Durham SR;
    JAMA; 2017 Feb; 317(6):615-625. PubMed ID: 28196255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.
    Murphy K; Gawchik S; Bernstein D; Andersen J; Pedersen MR
    J Negat Results Biomed; 2013 Jun; 12():10. PubMed ID: 23725348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen?
    Huss-Marp J; Darsow U; Brockow K; Pfab F; Weichenmeier I; Schober W; Petersson CJ; Borres MP; Ring J; Behrendt H
    Clin Exp Allergy; 2011 Aug; 41(8):1116-24. PubMed ID: 21518042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.